Story perspectives

Teva Recalls 580,000 Prazosin Capsules Over Cancer Risk

11/7/2025

35 7

Summary

Story summary

Teva Pharmaceuticals recalls over 580,000 bottles of Prazosin Hydrochloride capsules due to a potentially cancer-causing chemical.
FDA classifies the recall as Class II, indicating temporary health risks.
The recall covers 1 mg, 2 mg, and 5 mg Prazosin Hydrochloride capsules.
Veterans using Prazosin for PTSD-related nightmares and others with high blood pressure may be affected.
Patients should check affected lot numbers and consult a healthcare provider before changing medications.

1 of 1

Story summary

Teva Pharmaceuticals recalls over 580,000 bottles of Prazosin Hydrochloride capsules due to a potentially cancer-causing chemical.
FDA classifies the recall as Class II, indicating temporary health risks.
The recall covers 1 mg, 2 mg, and 5 mg Prazosin Hydrochloride capsules.
Veterans using Prazosin for PTSD-related nightmares and others with high blood pressure may be affected.
Patients should check affected lot numbers and consult a healthcare provider before changing medications.